Ridong Li

947 total citations
42 papers, 666 citations indexed

About

Ridong Li is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Ridong Li has authored 42 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Organic Chemistry and 11 papers in Cancer Research. Recurrent topics in Ridong Li's work include Cancer, Hypoxia, and Metabolism (8 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Synthesis and biological activity (5 papers). Ridong Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Synthesis and biological activity (5 papers). Ridong Li collaborates with scholars based in China, United States and Italy. Ridong Li's co-authors include Zemei Ge, Yuxin Yin, Runtao Li, Xianling Ning, Yan Jin, Hailong Qi, Michael A. McNutt, Zhiqiang Lin, Xin Zhang and Yunqiao Li and has published in prestigious journals such as Nature Communications, Cell Metabolism and The FASEB Journal.

In The Last Decade

Ridong Li

40 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ridong Li China 15 387 273 143 98 36 42 666
Eliud Hernandez O'Farril Puerto Rico 15 412 1.1× 246 0.9× 62 0.4× 124 1.3× 12 0.3× 31 755
Sunita Bhagat India 15 326 0.8× 364 1.3× 171 1.2× 225 2.3× 18 0.5× 66 904
Cornelis P. Vlaar Puerto Rico 14 476 1.2× 229 0.8× 62 0.4× 124 1.3× 11 0.3× 44 812
Jifeng Wu China 15 324 0.8× 387 1.4× 122 0.9× 192 2.0× 28 0.8× 34 824
Izabela Młynarczuk-Biały Poland 14 351 0.9× 155 0.6× 171 1.2× 220 2.2× 18 0.5× 42 732
Christine Lambert‐van der Brempt United Kingdom 11 520 1.3× 331 1.2× 72 0.5× 243 2.5× 19 0.5× 20 925
Guoshun Luo China 17 423 1.1× 301 1.1× 48 0.3× 274 2.8× 32 0.9× 46 858
James M. Hamby United States 17 542 1.4× 349 1.3× 80 0.6× 121 1.2× 16 0.4× 32 828
Renaud Prudent France 18 687 1.8× 186 0.7× 45 0.3× 188 1.9× 21 0.6× 37 1.1k
Asaad Nematalla United States 7 269 0.7× 240 0.9× 56 0.4× 123 1.3× 16 0.4× 13 547

Countries citing papers authored by Ridong Li

Since Specialization
Citations

This map shows the geographic impact of Ridong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ridong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ridong Li more than expected).

Fields of papers citing papers by Ridong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ridong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ridong Li. The network helps show where Ridong Li may publish in the future.

Co-authorship network of co-authors of Ridong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ridong Li. A scholar is included among the top collaborators of Ridong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ridong Li. Ridong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yuanyuan, Lidong Gong, Qiang Ma, et al.. (2025). A viral infection-biomimetic strategy for antibody-guided targeted protein degradation. Acta Biomaterialia. 205. 659–671.
2.
Ning, Xianling, Xi Chen, Ridong Li, et al.. (2025). Identification of a novel cuproptosis inducer that induces ER stress and oxidative stress to trigger immunogenic cell death in tumors. Free Radical Biology and Medicine. 229. 276–288. 3 indexed citations
3.
Li, Ridong, Zhaoming Chen, Li Su, et al.. (2024). PKM2 aggregation drives metabolism reprograming during aging process. Nature Communications. 15(1). 5761–5761. 9 indexed citations
4.
Li, Ridong, Lidong Gong, Junjie Huang, et al.. (2024). Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors. Bioorganic Chemistry. 144. 107134–107134. 3 indexed citations
5.
Gong, Lidong, Ridong Li, Xianling Ning, et al.. (2023). Discovery of a miniaturized PROTAC with potent activity and high selectivity. Bioorganic Chemistry. 136. 106556–106556. 15 indexed citations
6.
Ning, Xianling, Hailong Qi, Ridong Li, et al.. (2022). Identification of a new small molecule that initiates ferroptosis in cancer cells by inhibiting the system Xc− to deplete GSH. European Journal of Pharmacology. 934. 175304–175304. 9 indexed citations
7.
Zhou, Na, Hailong Qi, Junjun Liu, et al.. (2022). Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses. Cell Metabolism. 34(7). 1023–1041.e8. 36 indexed citations
8.
Li, Ridong, Xianling Ning, Jianan He, et al.. (2021). Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators. Bioorganic Chemistry. 108. 104653–104653. 8 indexed citations
9.
Wang, Zhongqing, et al.. (2020). Ruthenium-Catalyzed Highly Enantioselective Synthesis of cis-3-Quinuclidinols via DKR Asymmetric Transfer Hydrogenation. Organic Letters. 22(11). 4322–4326. 7 indexed citations
10.
Lin, Zhiqiang, Changrong Wang, Yang Li, et al.. (2019). Glutathione-Priming Nanoreactors Enable Fluorophore Core/Shell Transition for Precision Cancer Imaging. ACS Applied Materials & Interfaces. 11(37). 33667–33675. 7 indexed citations
11.
Feng, Yahui, Zhongqing Wang, Hongming Xie, et al.. (2019). Development of an Efficient and Scalable Biocatalytic Route to (1S,4R)-8-Hydroxy-1,2,3,4- tetrahydro-1,4-methanonaphthalen-5-yl Propionate via Enantioselective Enzymatic Desymmetrization of a Prochiral Diester. Organic Process Research & Development. 23(6). 1243–1251. 4 indexed citations
12.
Liu, Bin, Xia Yuan, Bo Xu, et al.. (2019). Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors. European Journal of Medicinal Chemistry. 170. 1–15. 27 indexed citations
13.
Zhao, Yuqiong, Ridong Li, Jianan He, et al.. (2018). Discovery and optimization of 2-thio-5-amino substituted benzoquinones as potent anticancer agents. European Journal of Medicinal Chemistry. 149. 1–9. 5 indexed citations
14.
Li, Ridong, Xianling Ning, Shuo Zhou, et al.. (2017). Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators. European Journal of Medicinal Chemistry. 143. 48–65. 20 indexed citations
15.
Han, Liqiang, Ridong Li, Bo Xu, et al.. (2017). Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors. Bioorganic & Medicinal Chemistry. 25(15). 4031–4044. 14 indexed citations
16.
Ning, Xianling, Hailong Qi, Ridong Li, et al.. (2017). Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase. European Journal of Medicinal Chemistry. 138. 343–352. 87 indexed citations
17.
Han, Liqiang, Xia Yuan, Xingyu Wu, et al.. (2016). Urea-containing peptide boronic acids as potent proteasome inhibitors. European Journal of Medicinal Chemistry. 125. 925–939. 26 indexed citations
18.
Li, Ying-Bo, Yan Xu, Ridong Li, et al.. (2016). Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry. 112. 217–230. 13 indexed citations
19.
Zhang, Yu, Bin Liu, Xingyu Wu, et al.. (2015). New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds. Bioorganic & Medicinal Chemistry. 23(15). 4815–4823. 44 indexed citations
20.
Li, Ridong, et al.. (2011). Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines. Bioorganic & Medicinal Chemistry Letters. 21(12). 3637–3640. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliud Hernandez O'Farril Breakdown of academic impact, for papers by Sunita Bhagat Breakdown of academic impact, for papers by Cornelis P. Vlaar Breakdown of academic impact, for papers by Jifeng Wu Breakdown of academic impact, for papers by Izabela Młynarczuk-Biały Breakdown of academic impact, for papers by Christine Lambert‐van der Brempt Breakdown of academic impact, for papers by Guoshun Luo Breakdown of academic impact, for papers by James M. Hamby Breakdown of academic impact, for papers by Renaud Prudent Breakdown of academic impact, for papers by Asaad Nematalla
Rankless by CCL
2026